Reducing Inflammation to Protect Kidney Health in Lupus Nephritis

Lupus nephritis, a severe complication of systemic lupus erythematosus (SLE), affects a significant portion of patients—approximately 15% to 30% are diagnosed with kidney inflammation early on, risking kidney failure. Over time, 30% to 50% of SLE patients may develop lupus nephritis, with half of these progressing to end-stage renal disease. Tackling this issue has traditionally involved immune-suppressing treatments, which suppress the body's immune response but increase vulnerability to infections.

Researchers at the Medical University of South Carolina, led by Dr. Jim Oates, are exploring an innovative approach that focuses on safeguarding renal endothelial cells—the cells lining the kidney's blood vessels. Their goal is to prevent immune cells from damaging kidney tissue by maintaining the health and function of these cells.

In recent studies published in Lupus Science & Medicine, the team examined how serum from lupus nephritis patients influences kidney endothelial cells. They found that during a flare, serum causes these cells to malfunction, leading to inflammation. However, when these cells were treated simultaneously with serum and the drug L-sepiterapin, inflammation was notably reduced. This drug enhances the production of nitric oxide—a molecule crucial for blood vessel health and inflammation control—thus offering a protective effect.

The team also identified that oxidative stress, prevalent in chronic conditions like obesity, smoking, and diabetes, impairs nitric oxide production by disabling the enzyme endothelial nitric oxide synthase (eNOS), leading to increased production of harmful free radicals like superoxide. This process exacerbates inflammation and tissue damage.

The innovative approach aims to modulate cell processes rather than suppress the entire immune system, reducing the risk of infections. By enhancing nitric oxide production through agents like L-sepiterapin, the strategy seeks to preserve kidney health and prevent organ damage. Dr. Oates likens this to preventing the immune system from attacking its own kidneys, similar to transplant rejection, but without compromising overall immunity.

If successful in further studies, this method could lead to new treatments for lupus nephritis and potentially other vascular-related conditions, including type 2 diabetes, by restoring endothelial cell function and reducing inflammation.

Source: https://medicalxpress.com/news/2025-08-dial-inflammation-lupus-nephritis.html